Cavex ImpreSafe effective against MRSA

Over the years we have received many questions on the effectiveness of Cavex ImpreSafe against the MRSA bacteria.

MRSA is the abbreviation of Methicillin Resistant Staphylococcus Aureus. It is a bacteria responsible for several difficult-to-treat infections in humans. Basically it is a strain of Staphylococcus aureus that has developed resistance to antibiotics (penicillin’s) Therefore a MRSA infection is very difficult to treat and thus dangerous. MRSA is especially troublesome in hospitals, prisons, and nursing homes, where patients with open wounds, invasive devices, and weakened immune systems are at greater risk. However, MRSA began as a hospital infection, but has developed to a community risk. 

Fortunately, Cavex ImpreSafe is effective against MRSA. In accordance with the relevant standard (EN1276) the Cavex ImpreSafe showed the required microbial reduction of > 5.0 log to the tested MRSA strain under dirty conditions (0.3% albumin – artificial blood) after a contact time of 1 minute at test temperature of 20°C.

Copy of the full test report is available on request at This email address is being protected from spambots. You need JavaScript enabled to view it.

Cavex Impresafe

 
Website design & development by Picturae